RPRX
Ticker
Royalty Pharma plc
RPRX · Healthcare · Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the U…Royalty Pharma plc (RPRX), in the Healthcare sector, has 35 disclosed filings on Paydirt over the trailing twelve months from 5 corporate insiders: 0 purchases and 35 sales, 1 filed past the deadline. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Aug 18 and filed Aug 19. The most active filer was Terrance P. Coyne with 14 filings.
Add to watchlistFilings, ttm
35
0 buys · 35 sells · 1 late
Traders, ttm
5
5 insiders
Volume, ttmiDollar value disclosed in the window
$85.8M
estimated for Congress, as filed for insiders
Median delay
2d
execution to disclosure
Last traded
Aug 18
Filed Aug 19
ADViAverage daily dollar volume
$206.7M
market data
Share price · 12M
$62.07 (+76.4%)
Adjusted for splits and dividends.
Volume by month
Buys $0
Sells $87.1M
Estimated for Congress, as filed for insiders · by filing month · past 24 months
Who filed
TCRecent filings
Christopher HiteSALE
EVP & Chairman, Partnering
$6.0M100,000 sh × $59.97
Exec Aug 18
Filed Aug 19 · 4:20 PM ET Terrance P. CoyneSALE EVP & CFO $646K
11,002 sh across 2 lots
Exec Aug 13
Filed Aug 17 · 5:01 PM ET Marshall UristSALE EVP, Research & Investments $508K
9,099 sh × $55.88
Exec Jul 1
Filed Jul 2 · 4:10 PM ET Christopher HiteSALE EVP & Chairman, Partnering $7.3M
129,400 sh across 3 lots
Exec Jun 30
Filed Jul 2 · 4:08 PM ET Christopher HiteSALE EVP & Chairman, Partnering $8.2M
150,000 sh across 2 lots
Exec Jun 23
Filed Jun 25 · 5:30 PM ET Marshall UristSALE EVP, Research & Investments $502K
9,098 sh × $55.18
Exec Jun 24
Filed Jun 25 · 5:30 PM ET Terrance P. CoyneSALE EVP & CFO $3.5M
64,399 sh × $53.98
Exec May 26
Filed May 28 · 5:30 PM ET Marshall UristSALE EVP, Research & Investments $722K
13,684 sh × $52.75
Exec May 20
Filed May 21 · 5:30 PM ET Gregory NordenSALE Director $161K
3,045 sh × $53.00
Exec May 14
Filed May 15 · 5:30 PM ET Marshall UristSALE EVP, Research & Investments $726K
13,684 sh × $53.06
Exec May 14
Filed May 15 · 5:30 PM ET Terrance P. CoyneSALE EVP & CFO $1.6M
32,916 sh × $49.78
Exec Apr 28
Filed Apr 30 · 5:30 PM ET Terrance P. CoyneSALE EVP & CFO $1.6M
32,916 sh × $48.33
Exec Apr 1
Filed Apr 2 · 5:30 PM ET Terrance P. CoyneSALE EVP & CFO $1.5M
32,916 sh × $45.53
Exec Mar 23
Filed Mar 25 · 5:30 PM ET Terrance P. CoyneSALE EVP & CFO $1.5M
32,916 sh across 2 lots
Exec Mar 2
Filed Mar 4 · 5:30 PM ET Terrance P. CoyneSALE EVP & CFO $1.5M
32,916 sh × $45.32
Exec Feb 23
Filed Feb 25 · 5:30 PM ET Terrance P. CoyneSALE EVP & CFO $10.3M
242,454 sh across 5 lots
Exec Feb 2
Filed Feb 4 · 5:30 PM ET Marshall UristSALE EVP, Research & Investments $822K
20,000 sh × $41.09
Exec Jan 30
Filed Feb 2 · 5:30 PM ET Marshall UristSALE EVP, Research & Investments $805K
20,000 sh × $40.26
Exec Jan 23
Filed Jan 26 · 5:30 PM ET Terrance P. CoyneSALE EVP & CFO $2.7M
69,582 sh across 2 lots
Exec Jan 20
Filed Jan 23 · 5:30 PM ET † Marshall UristSALE EVP, Research & Investments $790K
20,000 sh × $39.52
Exec Jan 16
Filed Jan 20 · 5:30 PM ET Marshall UristSALE EVP, Research & Investments $816K
20,000 sh × $40.78
Exec Jan 9
Filed Jan 13 · 5:30 PM ET Marshall UristSALE EVP, Research & Investments $770K
20,000 sh × $38.48
Exec Jan 2
Filed Jan 6 · 5:30 PM ET Terrance P. CoyneSALE EVP & CFO $2.7M
69,582 sh across 2 lots
Exec Jan 2
Filed Jan 6 · 5:30 PM ET Marshall UristSALE EVP, Research & Investments $786K
20,000 sh × $39.32
Exec Dec 26 2025
Filed Dec 29 2025 · 5:30 PM ET Marshall UristSALE EVP, Research & Investments $768K
20,000 sh × $38.38
Exec Dec 19 2025
Filed Dec 22 2025 · 5:30 PM ET